Log in
Enquire now
‌

US Patent 7658921 Molecules with extended half-lives, compositions and uses thereof

Patent 7658921 was granted and assigned to MedImmune on February, 2010 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
MedImmune
MedImmune
Date Filed
June 13, 2007
Date of Patent
February 9, 2010
Patent Application Number
11762525
Patent Citations Received
‌
US Patent 12018068 Anti-O1 antibodies and uses thereof
0
‌
US Patent 11767369 Molecules with altered neonate Fc receptor binding having enhanced therapeutic and diagnostic properties
‌
US Patent 11858980 Engineered polypeptides and uses thereof
0
‌
US Patent 11884719 Anti-IL-36 antibodies and methods of use thereof
0
‌
US Patent 11939383 B7-H4 antibodies and methods and use thereof
0
‌
US Patent 11970539 Antibodies that bind to IL1RAP and uses thereof
0
‌
US Patent 11993651 Anti-lag-3 antibodies and methods of use thereof
0
Patent Inventor Names
Herren Wu
0
Peter Kiener
0
William Dall'Acqua
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7658921
Patent Primary Examiner
‌
Michail A Belyavskyi

Find more entities like US Patent 7658921 Molecules with extended half-lives, compositions and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.